Lee Greenberger Discusses Blood Cancer Research and the Leukemia and Lymphoma Society

Oncology Nursing Stories: Off-The-Shelf CAR T Therapy for Acute Lymphoblastic Leukemia

Siltuximab May Be Effective Treatment for CRS/ICANS Following CAR T-Cell Therapy

ASH Data Offer Treatment Direction for Oncology Nursing Professionals

Educational Interventions Prove Beneficial for Caregivers of Pediatric Patients Receiving HSCT

Remote Patient Monitoring for CAR T Demonstrates Feasibility in the Outpatient Setting

Real-World Analysis Compares Inpatient and Outpatient CAR T-Cell Therapy in MCL and Follicular Lymphoma

Oncology Nursing Stories: Off-The-Shelf CAR T Therapy for Acute Lymphoblastic Leukemia

Siltuximab May Be Effective Treatment for CRS/ICANS Following CAR T-Cell Therapy

ASH Data Offer Treatment Direction for Oncology Nursing Professionals

Educational Interventions Prove Beneficial for Caregivers of Pediatric Patients Receiving HSCT

Remote Patient Monitoring for CAR T Demonstrates Feasibility in the Outpatient Setting

Real-World Analysis Compares Inpatient and Outpatient CAR T-Cell Therapy in MCL and Follicular Lymphoma

Oncology Nursing Stories: Off-The-Shelf CAR T Therapy for Acute Lymphoblastic Leukemia

Siltuximab May Be Effective Treatment for CRS/ICANS Following CAR T-Cell Therapy

ASH Data Offer Treatment Direction for Oncology Nursing Professionals

Educational Interventions Prove Beneficial for Caregivers of Pediatric Patients Receiving HSCT

Remote Patient Monitoring for CAR T Demonstrates Feasibility in the Outpatient Setting

Real-World Analysis Compares Inpatient and Outpatient CAR T-Cell Therapy in MCL and Follicular Lymphoma

Related Content

Oncology Nursing Stories: Off-The-Shelf CAR T Therapy for Acute Lymphoblastic Leukemia

Inpatient infusion was linked with greater comorbidity burden and increased likelihood of adverse effects in patients with follicular lymphoma who received CAR T-cell therapy, but not in those with mantle cell lymphoma.

Siltuximab May Be Effective Treatment for CRS/ICANS Following CAR T-Cell Therapy

Podcast

In this episode of The Vitals, Stephanie Jackson, DNP, MSN, RN, AOCNS, BMTCN, discusses the treatment journey of a patient who required multiple lines of therapy for ALL.

CAR T cell therapy © AkuAku - stock.adobe.com

ASH Data Offer Treatment Direction for Oncology Nursing Professionals

Siltuximab led to the complete resolution of cytokine release syndrome in 5 out of 6 patients, with a median time to complete response within 1 hour.

Educational Interventions Prove Beneficial for Caregivers of Pediatric Patients Receiving HSCT

Podcast

Nilesh Kalariya, PhD, AGPCNP-BC, AOCNP; and Laura J. Zitella, MS, RN, ACNP-BC, AOCN, discuss practice-changing presentations from the 64th American Society of Hematology Annual Meeting and Exposition.

Remote Patient Monitoring for CAR T Demonstrates Feasibility in the Outpatient Setting

Nurse researchers sought to improve the communication between the hematopoietic stem cell transplantation care team and pediatric patient caregivers.